In 2024, the Asia Pacific hospital-acquired disease testing market size was valued at USD 3.19 billion, a figure predicted to rise to a significant USD 11.51 billion by 2033, highlighting a promising Compound Annual Growth Rate (CAGR) of 15.32%. This exciting growth is propelled by the rising necessity for precise and swift diagnostic procedures capable…